Latest debt-to-equity ratio
Milestone Pharmaceuticals Debt-to-equity ratio
Direct answer
Milestone Pharmaceuticals's debt-to-equity ratio is 778.53%.
The verified market snapshot reports 778.53%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 5, 2026.
Get free Milestone Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 778.53%
Explore related company data
View Milestone Pharmaceuticals's market capitalizationView Milestone Pharmaceuticals's price-to-book ratioView Milestone Pharmaceuticals's return on equityView Milestone Pharmaceuticals's dividend yieldView Milestone Pharmaceuticals's 52-week price rangeView Milestone Pharmaceuticals's profit marginView all Milestone Pharmaceuticals key metricsReturn to Milestone Pharmaceuticals profile